This paper examines the ethical and marketing challenges facing Electronic Cigarettes Internal Group (ECIG), a manufacturer and distributor of vaporizers and e-cigarettes. It explores the central dilemma of whether e-cigarettes are genuinely harmful, contrasting U.S. regulatory skepticism with a Public Health England finding that vaporizers are approximately 95% less harmful than traditional tobacco. The paper analyzes ECIG's marketing strategy under CEO Dan O'Neill, including a 10,000-unit product giveaway in the U.K. and advertising approaches borrowed from traditional tobacco companies. It concludes by evaluating the tensions between ECIG's public health messaging, its sensual advertising tactics, and the cultural associations of vaping in the U.S. market.
Electronic Cigarettes Internal Group (ECIG) is a business that manufactures and sells vaporizers and electronic cigarettes. Various groups in the U.S. have labeled these products as harmful to health, even though a scientific review commissioned by the U.K. government identified them as approximately 95% less harmful than traditional tobacco cigarettes (Public Health England, 2015). ECIG nonetheless markets its products by promoting them as a healthy alternative to traditional cigarettes, citing the U.K. study as a reason for smokers to switch from tobacco to e-liquids. Essentially, ECIG positions itself as a tool to help tobacco smokers quit their habit.
The central ethical dilemma associated with the production and distribution of e-cigarettes and vaporizers is whether they are as harmful as traditional tobacco cigarettes — or whether they are harmful at all. Critics of the product argue that they are (Roloff, 2015), though there is speculation that some of these critics serve as mouthpieces for the tobacco lobby. The result is genuine uncertainty about whether vaporizers and e-liquids pose the same health risks as tobacco.
On the surface, it would appear that they do not, since e-liquids contain no actual tobacco — they are essentially water and flavoring. There is no risk of secondhand smoke, yet the prevailing perception in the U.S. is that vaporizers are equivalent to smoking cigarettes and should therefore be subject to the same restrictions and bans.
In the U.K., vaporizers are very common, and ECIG is especially prominent through its VIP brand. The company has established over 200 kiosks throughout the U.K. and maintains a strong footprint in the sector. The study by the U.K.'s health board offers a starkly different view of vaporizers compared to U.S. regulatory attitudes, suggesting that they represent a healthy pathway for traditional smokers to quit.
ECIG has addressed the ethical implications of its products through a focus on social responsibility, integrity, and business ethics, concentrating its marketing efforts in the U.K. where the reception of its products is considerably more positive. Following the publication of the U.K. health report on vaporizers, ECIG launched a 10,000-unit product giveaway leading up to New Year's Day 2016. The campaign focused on helping people fulfill a New Year's resolution to quit smoking by switching to vaporizers (Gwynn, 2015). The giveaway was a tremendous success — all units were dispensed in under 24 hours.
"Giveaway campaign and ethical marketing approach"
"CEO strategy tensions between health and seduction messaging"
Always verify citation format against your institution’s current style guide requirements.